Akt Determines Cell Fate Through Inhibition of the PERK-eIF2α Phosphorylation Pathway

Inhibition of a stress-response pathway renders tumor cells more susceptible to death induced by inhibitors of phosphoinositide 3-kinase signaling. Increasing the Chances of Death Regulation of mRNA translation affects cell growth, proliferation, and differentiation and involves several eukaryotic initiation factors (eIFs). Cells respond to various stresses by blocking the initiation of translation through the phosphorylation of the eIF2α subunit by a number of kinases, including PERK. Increased signaling by the kinases phosphoinositide 3-kinase (PI3K) and Akt is commonly observed in human cancers and leads to the phosphorylation of several proteins involved in the regulation of cell survival and proliferation. Mounir et al. found that the activity of PERK and the amount of phosphorylated eIF2α (eIF2αP) were increased in cells deficient in Akt signaling. The authors showed that Akt-mediated phosphorylation of PERK inhibited its activity and blocked the phosphorylation of eIF2α. In cells undergoing oxidative or endoplasmic reticulum stress, the PERK-eIF2αP pathway antagonized the activity of Akt. Finally, blocking the PERK-eIF2αP pathway rendered tumor cells more susceptible to death after treatment with inhibitors of PI3K-Akt signaling. These data suggest that Akt can control protein synthesis through the PERK-eIF2αP pathway and that inactivation of PERK and eIF2αP may improve the efficacy of therapies that target PI3K-Akt signaling. Metazoans respond to various forms of environmental stress by inducing the phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2α) at serine-51, a modification that leads to global inhibition of mRNA translation. We demonstrate induction of the phosphorylation of eIF2α in mammalian cells after either pharmacological inhibition of the phosphoinositide 3-kinase (PI3K)–Akt pathway or genetic or small interfering RNA–mediated ablation of Akt. This increase in the extent of eIF2α phosphorylation also occurred in Drosophila cells and depended on the endoplasmic reticulum (ER)–resident protein kinase PERK, which was inhibited by Akt-dependent phosphorylation at threonine-799. The activity of PERK and the abundance of phosphorylated eIF2α (eIF2αP) were reduced in mouse mammary gland tumors that contained activated Akt, as well as in cells exposed to ER stress or oxidative stress. In unstressed cells, the PERK-eIF2αP pathway mediated survival and facilitated adaptation to the deleterious effects of the inactivation of PI3K or Akt. Inactivation of the PERK-eIF2αP pathway increased the susceptibility of tumor cells to death by pharmacological inhibitors of PI3K or Akt. Thus, we suggest that the PERK-eIF2αP pathway provides a link between Akt signaling and translational control, which has implications for tumor formation and treatment.

[1]  Jing Wang,et al.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence , 2010, Nature.

[2]  Jiangbin Ye,et al.  PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage , 2010, Oncogene.

[3]  S. Formenti,et al.  Translational control in cancer , 2010, Nature Reviews Cancer.

[4]  G. Robertson,et al.  Tumor Suppression by PTEN Requires the Activation of the PKR-eIF2α Phosphorylation Pathway , 2009, Science Signaling.

[5]  Pixu Liu,et al.  Targeting the phosphoinositide 3-kinase pathway in cancer , 2009, Nature Reviews Drug Discovery.

[6]  D. Scheuner,et al.  Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. , 2009, Cell metabolism.

[7]  J. Blenis,et al.  Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.

[8]  C. Chresta,et al.  Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) , 2009, The Biochemical journal.

[9]  A. Hinnebusch,et al.  Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.

[10]  N. Hay,et al.  Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.

[11]  B. Wouters,et al.  Hypoxia signalling through mTOR and the unfolded protein response in cancer , 2008, Nature Reviews Cancer.

[12]  Gary Box,et al.  The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer . , 2008, Journal of medicinal chemistry.

[13]  Jennifer F. Raven,et al.  The eIF2α kinases inhibit vesicular stomatitis virus replication independently of eIF2 phosphorylation. , 2008 .

[14]  Jennifer F. Raven,et al.  PERK and PKR: Old kinases learn new tricks , 2008, Cell cycle.

[15]  C. Lindsley,et al.  The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. , 2008, Current cancer drug targets.

[16]  J. Pelletier,et al.  A Novel Function of eIF2α Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway , 2007 .

[17]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[18]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[19]  Y. Nomura,et al.  Akt up- and down-regulation in response to endoplasmic reticulum stress , 2007, Brain Research.

[20]  D. Charnock-Jones,et al.  Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  S. Gruber,et al.  Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway , 2006, Nature Cell Biology.

[22]  Afshin Samali,et al.  Mediators of endoplasmic reticulum stress‐induced apoptosis , 2006, EMBO reports.

[23]  J. Diehl,et al.  Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. , 2006, The international journal of biochemistry & cell biology.

[24]  T. Anthony,et al.  Coping with stress: eIF2 kinases and translational control. , 2006, Biochemical Society transactions.

[25]  C. Kumar,et al.  AKT crystal structure and AKT-specific inhibitors , 2005, Oncogene.

[26]  D. Scheuner,et al.  ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth , 2005, The EMBO journal.

[27]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[28]  L. Hendershot,et al.  The role of the unfolded protein response in tumour development: friend or foe? , 2004, Nature Reviews Cancer.

[29]  P. Hu,et al.  Critical Role of Endogenous Akt/IAPs and MEK1/ERK Pathways in Counteracting Endoplasmic Reticulum Stress-induced Cell Death* , 2004, Journal of Biological Chemistry.

[30]  James B. Mitchell,et al.  Oxidative stress, redox, and the tumor microenvironment. , 2004, Seminars in radiation oncology.

[31]  Robert D Cardiff,et al.  Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. , 2004, Cancer research.

[32]  I. Komuro,et al.  Akt-Induced Cellular Senescence: Implication for Human Disease , 2004, Cell cycle.

[33]  I. Komuro,et al.  Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21‐dependent pathway , 2004, The EMBO journal.

[34]  D. Alessi,et al.  Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. , 2003, The Biochemical journal.

[35]  Jennifer Skeen,et al.  Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.

[36]  A. Hinnebusch,et al.  Translational control by TOR and TAP42 through dephosphorylation of eIF2alpha kinase GCN2. , 2003, Genes & development.

[37]  R. Paules,et al.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.

[38]  A. Gingras,et al.  Activation of GCN2 in UV-Irradiated Cells Inhibits Translation , 2002, Current Biology.

[39]  Stevan R. Hubbard,et al.  IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA , 2002, Nature.

[40]  S. Orkin,et al.  Heme‐regulated eIF2α kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency , 2001, The EMBO journal.

[41]  E McEwen,et al.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis. , 2001, Molecular cell.

[42]  H. Atkins,et al.  Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.

[43]  D. Ron,et al.  Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase , 1999, Nature.

[44]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  N. Naidoo The Endoplasmic Reticulum Stress Response and Aging , 2009, Reviews in the neurosciences.

[46]  C. Lindsley,et al.  Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. , 2007, Current topics in medicinal chemistry.

[47]  J. Pelletier,et al.  A Novel Function of eIF 2 Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway , 2007 .